Inflammation, Immunity, and Vaccine Development for Helicobacter pylori

Anne Müller, Jay V Solnick

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The immune response to Helicobacter pylori entails both innate effectors and a complex mix of Th1, Th17, and Treg adaptive immune responses. The clinical outcome of infection may well depend to a large degree on the relative balance of these responses. Vaccination with a wide range of antigens, adjuvants, and delivery routes can produce statistically significant reductions in H. pylori colonization levels in mice, though rarely sterilizing immunity. Whether similar reductions in bacterial load can be achieved in humans, and whether they would be clinically significant, is still unclear. However, progress in understanding the role of Th1, Th17, and most recently Treg cells in protection against H. pylori infection provides reason for optimism.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalHelicobacter
Volume16
Issue numberSUPPL. 1
DOIs
StatePublished - Sep 2011

Fingerprint

Helicobacter pylori
Immunity
Vaccines
Inflammation
Cytoprotection
Bacterial Load
Helicobacter Infections
Adaptive Immunity
Regulatory T-Lymphocytes
Vaccination
Antigens
Infection
Optimism

Keywords

  • Antigens
  • Immunomodulation
  • Innate immunity
  • T-helper

ASJC Scopus subject areas

  • Gastroenterology
  • Infectious Diseases

Cite this

Inflammation, Immunity, and Vaccine Development for Helicobacter pylori. / Müller, Anne; Solnick, Jay V.

In: Helicobacter, Vol. 16, No. SUPPL. 1, 09.2011, p. 26-32.

Research output: Contribution to journalArticle

@article{013920a9114f4d7dbd57d4a23ad605c8,
title = "Inflammation, Immunity, and Vaccine Development for Helicobacter pylori",
abstract = "The immune response to Helicobacter pylori entails both innate effectors and a complex mix of Th1, Th17, and Treg adaptive immune responses. The clinical outcome of infection may well depend to a large degree on the relative balance of these responses. Vaccination with a wide range of antigens, adjuvants, and delivery routes can produce statistically significant reductions in H. pylori colonization levels in mice, though rarely sterilizing immunity. Whether similar reductions in bacterial load can be achieved in humans, and whether they would be clinically significant, is still unclear. However, progress in understanding the role of Th1, Th17, and most recently Treg cells in protection against H. pylori infection provides reason for optimism.",
keywords = "Antigens, Immunomodulation, Innate immunity, T-helper",
author = "Anne M{\"u}ller and Solnick, {Jay V}",
year = "2011",
month = "9",
doi = "10.1111/j.1523-5378.2011.00877.x",
language = "English (US)",
volume = "16",
pages = "26--32",
journal = "Helicobacter",
issn = "1083-4389",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Inflammation, Immunity, and Vaccine Development for Helicobacter pylori

AU - Müller, Anne

AU - Solnick, Jay V

PY - 2011/9

Y1 - 2011/9

N2 - The immune response to Helicobacter pylori entails both innate effectors and a complex mix of Th1, Th17, and Treg adaptive immune responses. The clinical outcome of infection may well depend to a large degree on the relative balance of these responses. Vaccination with a wide range of antigens, adjuvants, and delivery routes can produce statistically significant reductions in H. pylori colonization levels in mice, though rarely sterilizing immunity. Whether similar reductions in bacterial load can be achieved in humans, and whether they would be clinically significant, is still unclear. However, progress in understanding the role of Th1, Th17, and most recently Treg cells in protection against H. pylori infection provides reason for optimism.

AB - The immune response to Helicobacter pylori entails both innate effectors and a complex mix of Th1, Th17, and Treg adaptive immune responses. The clinical outcome of infection may well depend to a large degree on the relative balance of these responses. Vaccination with a wide range of antigens, adjuvants, and delivery routes can produce statistically significant reductions in H. pylori colonization levels in mice, though rarely sterilizing immunity. Whether similar reductions in bacterial load can be achieved in humans, and whether they would be clinically significant, is still unclear. However, progress in understanding the role of Th1, Th17, and most recently Treg cells in protection against H. pylori infection provides reason for optimism.

KW - Antigens

KW - Immunomodulation

KW - Innate immunity

KW - T-helper

UR - http://www.scopus.com/inward/record.url?scp=80052546541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052546541&partnerID=8YFLogxK

U2 - 10.1111/j.1523-5378.2011.00877.x

DO - 10.1111/j.1523-5378.2011.00877.x

M3 - Article

C2 - 21896082

AN - SCOPUS:80052546541

VL - 16

SP - 26

EP - 32

JO - Helicobacter

JF - Helicobacter

SN - 1083-4389

IS - SUPPL. 1

ER -